Insights

Strong R&D Focus Inbiose's expertise in developing proprietary human milk oligosaccharides and specialty carbohydrates positions it as a key innovator in the infant nutrition and healthcare markets, providing opportunities to partner for advanced nutrition products.

Strategic Industry Collaborations Partnerships with industry leaders like DuPont and investments from the European Investment Bank demonstrate credibility and potential for expanding commercial scale, opening avenues for scaled supply and co-development projects.

Emerging Market Demand Growing consumer awareness of gut health and infant nutrition presents significant sales opportunities for Inbiose’s sustainable, cost-effective oligosaccharides across consumer products, supplements, and cosmetics.

Innovation & Product Pipeline Inbiose’s rapid development platform and ability to accelerate product commercialization make it an ideal partner for companies seeking to incorporate cutting-edge, scientifically validated carbohydrates into their offerings.

Sustainable Production Advantage Utilizing sustainable fermentation processes to produce human milk oligosaccharides at low cost provides a competitive edge for supply chain partners aiming for environmentally friendly and cost-efficient health ingredients.

Inbiose Tech Stack

Inbiose uses 8 technology products and services including Open Graph, NoSQL, Jupyter, and more. Explore Inbiose's tech stack below.

  • Open Graph
    Content Management System
  • NoSQL
    Database
  • Jupyter
    File Sharing
  • core-js
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • Linux
    Programming Languages
  • Plyr
    Video Players
  • HTTP/3
    Web & Portal Technology

Inbiose's Email Address Formats

Inbiose uses at least 1 format(s):
Inbiose Email FormatsExamplePercentage
First.Last@inbiose.comJohn.Doe@inbiose.com
81%
Last@inbiose.comDoe@inbiose.com
11%
First.MiddleLast@inbiose.comJohn.MichaelDoe@inbiose.com
6%
First.Middle@inbiose.comJohn.Michael@inbiose.com
2%

Frequently Asked Questions

Where is Inbiose's headquarters located?

Minus sign iconPlus sign icon
Inbiose's main headquarters is located at Technologiepark, Ghent, East Flanders 9052, BE. The company has employees across 1 continents, including Europe.

What is Inbiose's official website and social media links?

Minus sign iconPlus sign icon
Inbiose's official website is inbiose.com and has social profiles on LinkedInCrunchbase.

What is Inbiose's SIC code NAICS code?

Minus sign iconPlus sign icon
Inbiose's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Inbiose have currently?

Minus sign iconPlus sign icon
As of October 2025, Inbiose has approximately 55 employees across 1 continents, including Europe. Key team members include Ceo/ Cfo: B. F.Chief Commercial Officer (cco): D. A.Chief Operating Officer: J. S.. Explore Inbiose's employee directory with LeadIQ.

What industry does Inbiose belong to?

Minus sign iconPlus sign icon
Inbiose operates in the Biotechnology Research industry.

What technology does Inbiose use?

Minus sign iconPlus sign icon
Inbiose's tech stack includes Open GraphNoSQLJupytercore-jsSlider RevolutionLinuxPlyrHTTP/3.

What is Inbiose's email format?

Minus sign iconPlus sign icon
Inbiose's email format typically follows the pattern of First.Last@inbiose.com. Find more Inbiose email formats with LeadIQ.

How much funding has Inbiose raised to date?

Minus sign iconPlus sign icon
As of October 2025, Inbiose has raised $18M in funding. The last funding round occurred on Jul 14, 2021 for $18M.

When was Inbiose founded?

Minus sign iconPlus sign icon
Inbiose was founded in 2013.

Inbiose

Biotechnology ResearchBelgium51-200 Employees

“Dedicated to specialty carbohydrates for human health and beyond”

Inbiose is dedicated to improving human health by making specialty oligosaccharides available for mainstream use. We strive to make available to the consumer the health benefits these complex sugars can bring to human and infant health, as well as specialized nutrition, cosmetics and beyond.

Inbiose is a leading company in the development of Human Milk Oligosaccharides, which are of paramount importance for the health of newborns and developing infants.

Our competences lie in the rapid development and cost-effective production of innovative specialty carbohydrates otherwise unavailable to society at large.

Our development pipeline allows us to offer a high-throughput development platform, as well as process development, scale-up and regulatory services that compressing new product development cycles and minimizes time to market.

Section iconCompany Overview

Headquarters
Technologiepark, Ghent, East Flanders 9052, BE
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $18M

    Inbiose has raised a total of $18M of funding over 1 rounds. Their latest funding round was raised on Jul 14, 2021 in the amount of $18M.

  • $1M

    Inbiose's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $18M

    Inbiose has raised a total of $18M of funding over 1 rounds. Their latest funding round was raised on Jul 14, 2021 in the amount of $18M.

  • $1M

    Inbiose's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.